• レポートコード:MRC2-11QY11719 • 出版社/出版日:QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、97ページ • 納品方法:Eメール(納期:2~3日) • 産業分類:ヘルスケア |
Single User | ¥585,000 (USD3,900) | ▷ お問い合わせ |
Multi User | ¥877,500 (USD5,850) | ▷ お問い合わせ |
Enterprise License | ¥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は乱用薬物検査のグローバル市場について調査・分析したレポートです。種類別(オンサイトスクリーニング検査、実験室薬物検査)市場規模、用途別(医療、研究所)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別乱用薬物検査の競争状況、市場シェア ・世界の乱用薬物検査市場:種類別市場規模 2015年-2020年(オンサイトスクリーニング検査、実験室薬物検査) ・世界の乱用薬物検査市場:種類別市場規模予測 2021年-2026年(オンサイトスクリーニング検査、実験室薬物検査) ・世界の乱用薬物検査市場:用途別市場規模 2015年-2020年(医療、研究所) ・世界の乱用薬物検査市場:用途別市場規模予測 2021年-2026年(医療、研究所) ・北米の乱用薬物検査市場分析:米国、カナダ ・ヨーロッパの乱用薬物検査市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの乱用薬物検査市場分析:日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の乱用薬物検査市場分析:メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの乱用薬物検査市場分析:トルコ、サウジアラビア、UAE等 ・企業情報(企業概要、製品概要、販売量、企業動向) - 掲載企業(変更可能性あり):Roche Holding、Quest Diagnostics、Abbott、Abbott Laboratories、Randox Laboratories、Psychemedics Corporation、Bio-Rad Laboratories、Sonic Healthcare、Thermo Fisher Scientific ・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Drug of abuse testing is based on diagnosing drug addiction, also called substance use disorder, requiring a thorough evaluation and often includes an assessment by a psychiatrist, a psychologist, or a licensed alcohol and drug counselor. Blood, urine or other lab tests are used to assess drug use, but they’re not a diagnostic test for addiction. These tests may be used for monitoring treatment.
The factor which may influence the growth of the drug of abuse testing market is increased use of drug testing at organizational level, increased production and trade of illicit drugs worldwide and others. Globally the market for drug of abuse testing is expected to grow at 5.8% GAGR from 2017 to 2025.
Market Analysis and Insights: Global Drug of Abuse Testing Market
The global Drug of Abuse Testing market size is projected to reach US$ 4317.5 million by 2026, from US$ 4191.6 million in 2020, at a CAGR of 2.8%% during 2021-2026.
Global Drug of Abuse Testing Scope and Market Size
Drug of Abuse Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Drug of Abuse Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Roche Holding
Quest Diagnostics
Abbott
Abbott Laboratories
Randox Laboratories
Psychemedics Corporation
Bio-Rad Laboratories
Sonic Healthcare
Thermo Fisher Scientific
Market segment by Type, the product can be split into
Onsite Screening Test
Laboratory Drug Testing
Market segment by Application, split into
Healthcare
Laboratory
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Drug of Abuse Testing Revenue
1.4 Market by Type
1.4.1 Global Drug of Abuse Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Onsite Screening Test
1.4.3 Laboratory Drug Testing
1.5 Market by Application
1.5.1 Global Drug of Abuse Testing Market Share by Application: 2020 VS 2026
1.5.2 Healthcare
1.5.3 Laboratory
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Drug of Abuse Testing Market Perspective (2015-2026)
2.2 Global Drug of Abuse Testing Growth Trends by Regions
2.2.1 Drug of Abuse Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Drug of Abuse Testing Historic Market Share by Regions (2015-2020)
2.2.3 Drug of Abuse Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Drug of Abuse Testing Market Growth Strategy
2.3.6 Primary Interviews with Key Drug of Abuse Testing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Drug of Abuse Testing Players by Market Size
3.1.1 Global Top Drug of Abuse Testing Players by Revenue (2015-2020)
3.1.2 Global Drug of Abuse Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global Drug of Abuse Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Drug of Abuse Testing Market Concentration Ratio
3.2.1 Global Drug of Abuse Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Drug of Abuse Testing Revenue in 2019
3.3 Drug of Abuse Testing Key Players Head office and Area Served
3.4 Key Players Drug of Abuse Testing Product Solution and Service
3.5 Date of Enter into Drug of Abuse Testing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Drug of Abuse Testing Historic Market Size by Type (2015-2020)
4.2 Global Drug of Abuse Testing Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Drug of Abuse Testing Market Size by Application (2015-2020)
5.2 Global Drug of Abuse Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Drug of Abuse Testing Market Size (2015-2020)
6.2 Drug of Abuse Testing Key Players in North America (2019-2020)
6.3 North America Drug of Abuse Testing Market Size by Type (2015-2020)
6.4 North America Drug of Abuse Testing Market Size by Application (2015-2020)
7 Europe
7.1 Europe Drug of Abuse Testing Market Size (2015-2020)
7.2 Drug of Abuse Testing Key Players in Europe (2019-2020)
7.3 Europe Drug of Abuse Testing Market Size by Type (2015-2020)
7.4 Europe Drug of Abuse Testing Market Size by Application (2015-2020)
8 China
8.1 China Drug of Abuse Testing Market Size (2015-2020)
8.2 Drug of Abuse Testing Key Players in China (2019-2020)
8.3 China Drug of Abuse Testing Market Size by Type (2015-2020)
8.4 China Drug of Abuse Testing Market Size by Application (2015-2020)
9 Japan
9.1 Japan Drug of Abuse Testing Market Size (2015-2020)
9.2 Drug of Abuse Testing Key Players in Japan (2019-2020)
9.3 Japan Drug of Abuse Testing Market Size by Type (2015-2020)
9.4 Japan Drug of Abuse Testing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Drug of Abuse Testing Market Size (2015-2020)
10.2 Drug of Abuse Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Drug of Abuse Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Drug of Abuse Testing Market Size by Application (2015-2020)
11 India
11.1 India Drug of Abuse Testing Market Size (2015-2020)
11.2 Drug of Abuse Testing Key Players in India (2019-2020)
11.3 India Drug of Abuse Testing Market Size by Type (2015-2020)
11.4 India Drug of Abuse Testing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Drug of Abuse Testing Market Size (2015-2020)
12.2 Drug of Abuse Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Drug of Abuse Testing Market Size by Type (2015-2020)
12.4 Central & South America Drug of Abuse Testing Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Roche Holding
13.1.1 Roche Holding Company Details
13.1.2 Roche Holding Business Overview
13.1.3 Roche Holding Drug of Abuse Testing Introduction
13.1.4 Roche Holding Revenue in Drug of Abuse Testing Business (2015-2020))
13.1.5 Roche Holding Recent Development
13.2 Quest Diagnostics
13.2.1 Quest Diagnostics Company Details
13.2.2 Quest Diagnostics Business Overview
13.2.3 Quest Diagnostics Drug of Abuse Testing Introduction
13.2.4 Quest Diagnostics Revenue in Drug of Abuse Testing Business (2015-2020)
13.2.5 Quest Diagnostics Recent Development
13.3 Abbott
13.3.1 Abbott Company Details
13.3.2 Abbott Business Overview
13.3.3 Abbott Drug of Abuse Testing Introduction
13.3.4 Abbott Revenue in Drug of Abuse Testing Business (2015-2020)
13.3.5 Abbott Recent Development
13.4 Abbott Laboratories
13.4.1 Abbott Laboratories Company Details
13.4.2 Abbott Laboratories Business Overview
13.4.3 Abbott Laboratories Drug of Abuse Testing Introduction
13.4.4 Abbott Laboratories Revenue in Drug of Abuse Testing Business (2015-2020)
13.4.5 Abbott Laboratories Recent Development
13.5 Randox Laboratories
13.5.1 Randox Laboratories Company Details
13.5.2 Randox Laboratories Business Overview
13.5.3 Randox Laboratories Drug of Abuse Testing Introduction
13.5.4 Randox Laboratories Revenue in Drug of Abuse Testing Business (2015-2020)
13.5.5 Randox Laboratories Recent Development
13.6 Psychemedics Corporation
13.6.1 Psychemedics Corporation Company Details
13.6.2 Psychemedics Corporation Business Overview
13.6.3 Psychemedics Corporation Drug of Abuse Testing Introduction
13.6.4 Psychemedics Corporation Revenue in Drug of Abuse Testing Business (2015-2020)
13.6.5 Psychemedics Corporation Recent Development
13.7 Bio-Rad Laboratories
13.7.1 Bio-Rad Laboratories Company Details
13.7.2 Bio-Rad Laboratories Business Overview
13.7.3 Bio-Rad Laboratories Drug of Abuse Testing Introduction
13.7.4 Bio-Rad Laboratories Revenue in Drug of Abuse Testing Business (2015-2020)
13.7.5 Bio-Rad Laboratories Recent Development
13.8 Sonic Healthcare
13.8.1 Sonic Healthcare Company Details
13.8.2 Sonic Healthcare Business Overview
13.8.3 Sonic Healthcare Drug of Abuse Testing Introduction
13.8.4 Sonic Healthcare Revenue in Drug of Abuse Testing Business (2015-2020)
13.8.5 Sonic Healthcare Recent Development
13.9 Thermo Fisher Scientific
13.9.1 Thermo Fisher Scientific Company Details
13.9.2 Thermo Fisher Scientific Business Overview
13.9.3 Thermo Fisher Scientific Drug of Abuse Testing Introduction
13.9.4 Thermo Fisher Scientific Revenue in Drug of Abuse Testing Business (2015-2020)
13.9.5 Thermo Fisher Scientific Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Drug of Abuse Testing Key Market Segments
Table 2. Key Players Covered: Ranking by Drug of Abuse Testing Revenue
Table 3. Ranking of Global Top Drug of Abuse Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Drug of Abuse Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Onsite Screening Test
Table 6. Key Players of Laboratory Drug Testing
Table 7. Global Drug of Abuse Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Drug of Abuse Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Drug of Abuse Testing Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Drug of Abuse Testing Market Share by Regions (2015-2020)
Table 11. Global Drug of Abuse Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Drug of Abuse Testing Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Drug of Abuse Testing Market Growth Strategy
Table 17. Main Points Interviewed from Key Drug of Abuse Testing Players
Table 18. Global Drug of Abuse Testing Revenue by Players (2015-2020) (Million US$)
Table 19. Global Drug of Abuse Testing Market Share by Players (2015-2020)
Table 20. Global Top Drug of Abuse Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug of Abuse Testing as of 2019)
Table 21. Global Drug of Abuse Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Drug of Abuse Testing Product Solution and Service
Table 24. Date of Enter into Drug of Abuse Testing Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Drug of Abuse Testing Market Size by Type (2015-2020) (Million US$)
Table 27. Global Drug of Abuse Testing Market Size Share by Type (2015-2020)
Table 28. Global Drug of Abuse Testing Revenue Market Share by Type (2021-2026)
Table 29. Global Drug of Abuse Testing Market Size Share by Application (2015-2020)
Table 30. Global Drug of Abuse Testing Market Size by Application (2015-2020) (Million US$)
Table 31. Global Drug of Abuse Testing Market Size Share by Application (2021-2026)
Table 32. North America Key Players Drug of Abuse Testing Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Drug of Abuse Testing Market Share (2019-2020)
Table 34. North America Drug of Abuse Testing Market Size by Type (2015-2020) (Million US$)
Table 35. North America Drug of Abuse Testing Market Share by Type (2015-2020)
Table 36. North America Drug of Abuse Testing Market Size by Application (2015-2020) (Million US$)
Table 37. North America Drug of Abuse Testing Market Share by Application (2015-2020)
Table 38. Europe Key Players Drug of Abuse Testing Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Drug of Abuse Testing Market Share (2019-2020)
Table 40. Europe Drug of Abuse Testing Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Drug of Abuse Testing Market Share by Type (2015-2020)
Table 42. Europe Drug of Abuse Testing Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Drug of Abuse Testing Market Share by Application (2015-2020)
Table 44. China Key Players Drug of Abuse Testing Revenue (2019-2020) (Million US$)
Table 45. China Key Players Drug of Abuse Testing Market Share (2019-2020)
Table 46. China Drug of Abuse Testing Market Size by Type (2015-2020) (Million US$)
Table 47. China Drug of Abuse Testing Market Share by Type (2015-2020)
Table 48. China Drug of Abuse Testing Market Size by Application (2015-2020) (Million US$)
Table 49. China Drug of Abuse Testing Market Share by Application (2015-2020)
Table 50. Japan Key Players Drug of Abuse Testing Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Drug of Abuse Testing Market Share (2019-2020)
Table 52. Japan Drug of Abuse Testing Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Drug of Abuse Testing Market Share by Type (2015-2020)
Table 54. Japan Drug of Abuse Testing Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Drug of Abuse Testing Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Drug of Abuse Testing Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Drug of Abuse Testing Market Share (2019-2020)
Table 58. Southeast Asia Drug of Abuse Testing Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Drug of Abuse Testing Market Share by Type (2015-2020)
Table 60. Southeast Asia Drug of Abuse Testing Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Drug of Abuse Testing Market Share by Application (2015-2020)
Table 62. India Key Players Drug of Abuse Testing Revenue (2019-2020) (Million US$)
Table 63. India Key Players Drug of Abuse Testing Market Share (2019-2020)
Table 64. India Drug of Abuse Testing Market Size by Type (2015-2020) (Million US$)
Table 65. India Drug of Abuse Testing Market Share by Type (2015-2020)
Table 66. India Drug of Abuse Testing Market Size by Application (2015-2020) (Million US$)
Table 67. India Drug of Abuse Testing Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Drug of Abuse Testing Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Drug of Abuse Testing Market Share (2019-2020)
Table 70. Central & South America Drug of Abuse Testing Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Drug of Abuse Testing Market Share by Type (2015-2020)
Table 72. Central & South America Drug of Abuse Testing Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Drug of Abuse Testing Market Share by Application (2015-2020)
Table 74. Roche Holding Company Details
Table 75. Roche Holding Business Overview
Table 76. Roche Holding Product
Table 77. Roche Holding Revenue in Drug of Abuse Testing Business (2015-2020) (Million US$)
Table 78. Roche Holding Recent Development
Table 79. Quest Diagnostics Company Details
Table 80. Quest Diagnostics Business Overview
Table 81. Quest Diagnostics Product
Table 82. Quest Diagnostics Revenue in Drug of Abuse Testing Business (2015-2020) (Million US$)
Table 83. Quest Diagnostics Recent Development
Table 84. Abbott Company Details
Table 85. Abbott Business Overview
Table 86. Abbott Product
Table 87. Abbott Revenue in Drug of Abuse Testing Business (2015-2020) (Million US$)
Table 88. Abbott Recent Development
Table 89. Abbott Laboratories Company Details
Table 90. Abbott Laboratories Business Overview
Table 91. Abbott Laboratories Product
Table 92. Abbott Laboratories Revenue in Drug of Abuse Testing Business (2015-2020) (Million US$)
Table 93. Abbott Laboratories Recent Development
Table 94. Randox Laboratories Company Details
Table 95. Randox Laboratories Business Overview
Table 96. Randox Laboratories Product
Table 97. Randox Laboratories Revenue in Drug of Abuse Testing Business (2015-2020) (Million US$)
Table 98. Randox Laboratories Recent Development
Table 99. Psychemedics Corporation Company Details
Table 100. Psychemedics Corporation Business Overview
Table 101. Psychemedics Corporation Product
Table 102. Psychemedics Corporation Revenue in Drug of Abuse Testing Business (2015-2020) (Million US$)
Table 103. Psychemedics Corporation Recent Development
Table 104. Bio-Rad Laboratories Company Details
Table 105. Bio-Rad Laboratories Business Overview
Table 106. Bio-Rad Laboratories Product
Table 107. Bio-Rad Laboratories Revenue in Drug of Abuse Testing Business (2015-2020) (Million US$)
Table 108. Bio-Rad Laboratories Recent Development
Table 109. Sonic Healthcare Business Overview
Table 110. Sonic Healthcare Product
Table 111. Sonic Healthcare Company Details
Table 112. Sonic Healthcare Revenue in Drug of Abuse Testing Business (2015-2020) (Million US$)
Table 113. Sonic Healthcare Recent Development
Table 114. Thermo Fisher Scientific Company Details
Table 115. Thermo Fisher Scientific Business Overview
Table 116. Thermo Fisher Scientific Product
Table 117. Thermo Fisher Scientific Revenue in Drug of Abuse Testing Business (2015-2020) (Million US$)
Table 118. Thermo Fisher Scientific Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug of Abuse Testing Market Share by Type: 2020 VS 2026
Figure 2. Onsite Screening Test Features
Figure 3. Laboratory Drug Testing Features
Figure 4. Global Drug of Abuse Testing Market Share by Application: 2020 VS 2026
Figure 5. Healthcare Case Studies
Figure 6. Laboratory Case Studies
Figure 7. Drug of Abuse Testing Report Years Considered
Figure 8. Global Drug of Abuse Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Drug of Abuse Testing Market Share by Regions: 2020 VS 2026
Figure 10. Global Drug of Abuse Testing Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Drug of Abuse Testing Market Share by Players in 2019
Figure 13. Global Top Drug of Abuse Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug of Abuse Testing as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Drug of Abuse Testing Revenue in 2019
Figure 15. North America Drug of Abuse Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Drug of Abuse Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Drug of Abuse Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Drug of Abuse Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Drug of Abuse Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Drug of Abuse Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Drug of Abuse Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed